ReviewBlood research2025
Beyond anemia: unraveling neutrophil defects and infection susceptibility in β-Thalassemia.
Review in Blood research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Species distribution and antifungal susceptibility patterns of oral Candida colonization and infection in β-thalassemia major patients.BMC oral health · 2026Article
- Iron Overload-Associated Oxidative Stress and Immune Cell Dysfunction in Thalassemia: Integrative Analysis of Hematological, Biochemical, and Flow Cytometric Biomarkers.Antioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
β-Thalassemia is characterized by defective β-globin synthesis and chronic transfusion dependence. Beyond anemia and iron overload, patients with β-thalassemia display heightened susceptibility to infections. Neutrophil granulocytes (NGs) are crucial innate immune cells that protect against bacteria through phagocytosis, degranulation, generation of reactive oxygen species (ROS), and neutrophil extracellular trap (NET) formation. Neutrophils in patients with thalassemia exhibit impaired functions, including defective chemotaxis, reduced phagocytic killing, attenuated respiratory burst, and abnormal NET formation. Chronic immune activation and iron overload, with consequent oxidative stress, are key contributors to these defects. Iron accumulation leads to excess free iron and heme, catalyzing ROS production that damages neutrophil membranes and enzymes and induces heme oxygenase-1 (HO-1), which suppresses immune responses. Neutrophils from patients with thalassemia often show an immature phenotype and increased apoptosis, further compromising innate immunity. A growing body of evidence confirms that systemic iron overload is inversely correlated with neutrophil bactericidal activity. These neutrophil defects contribute to the high risk of infection in thalassemia. Therapeutic strategies such as intensive iron chelation, antioxidants, and modulation of the HO-1 pathway hold promise for restoring neutrophil function. A deeper understanding of these mechanisms may guide the development of new interventions to reduce infectious complications and improve patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.